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Abstract: 
Diabetes mellitus is one of the leading incurable diseases which may lead to 
severe health complications due to elevated blood glucose levels. This is mainly 
caused due to lack of insulin secretion by pancreas (Type I) or when the cells in 
the body become resistant to insulin (Type II). The key for diabetes treatment is 
regular monitoring and maintenance of blood glucose levels in the body. We 
present herein an optical glucose biosensor for glucose monitoring, where a 
fluorescent enzymatic hydrogel is incorporated with fluorescein, polyethylene 
glycol and glucose oxidase. Glucose oxidase catalyzes oxidation of glucose to 
gluconic acid that protonates pH-sensitive fluorescein motif in hydrogel and thus 
significantly varies its fluorescence which was optically measured and correlated 
with glucose concentration. Therefore, fluorescence “turn-off” response is 
observed when glucose responsive hydrogel is exposed to glucose.  
The development of fluorescent hydrogel further encouraged to develop a 
fluorescent hydrogel fiber as a potentially optical injectable glucose biosensor for 
continuous in-vivo glucose monitoring. Both glucose-responsive hydrogel sensor 
and glucose-responsive hydrogel fiber shows good sensitivity and reproducibility, 
with the fiber showing much faster response time for glucose detection. The 
developed glucose biosensing technique has great potential in combating 
diabetics. 
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Chapter 1 
Introduction 
1.1 Diabetes and Glucose detection 
Diabetes 
Diabetes is a metabolic disorder and a major world health problem. As stated by 
International Diabetes Federation, there are over 285 million people worldwide 
living with diabetes in 2010. This number is projected to double in 2030. Currently, 
the top five nations in terms of diabetic patients are China (92.4 million), India (50.8 
million), US (26.8 million), Russia (9.6 million), and Brazil (7.6 million), spanning 
both developing and developed countries and covering diverse geographic areas. 
Due to the extremely large financial burden caused by diabetes and its serious 
complications, glucose detection is becoming important in battling diabetes and 
reducing financial loss [1]. Additionally, the US market for diabetic monitoring 
reached $9.1 billion in 2010. Therefore, glucose detection has profound social and 
economic implications. 
One of the important functions of pancreas in human body is to produce insulin 
which regulates blood glucose levels in the body. Diabetes is caused due to lack 
of insulin secretion by pancreas (Type I) or when the cells in the body become 
resistant to insulin (Type II). Both low glucose levels and high glucose levels in the 
body are dangerous, thus it is very important to maintain body blood glucose 
levels. Though the administration of insulin and control of diet have allowed 
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patients to lead nearly normal lives, rigorous maintenance of glucose levels is 
necessary to slow the progression of long-term complications associated with 
diabetes [2, 3].   
Two major situations that deal with diabetes are hyperglycemia and hypoglycemia. 
These two are further known for different complications. Hyperglycemia is a 
situation where the body glucose level falls below the normal required level. It 
brings down patient’s blood pressure level and leads to dizziness, shaking, 
sweating, and sometimes patient fall unconscious, which has to be taken care 
immediately. On other hand hyperglycemia is a situation where the body glucose 
level rises way more than the normal glucose level (i.e., more than 180 mg/dl). 
Hyperglycemia is also called Diabetes, which when not taken care in time leads to 
death. 
Although there is no cure for the disease, the only key for the treatment is tight 
glucose control substantially reduces morbidity and mortality among diabetes 
patients. Therefore, there is urgency for glucose detection because of serious 
health complications of diabetes.  
 
Glucose Detection 
Currently strip-based electrochemical glucose self-testing systems rely on glucose 
oxidase (GOx)-based or glucose dehydrogenase (GDH)-based glucose detection 
methods. Although they dominate the market and are widely used by diabetes 
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patients at home, the pain associated with the fingerstick can deter patients from 
frequent monitoring [4], resulting in a poor approximation of blood glucose 
variations [1(a)]. As a result, there is an urgent need to develop non-invasive or 
minimally invasive methods for frequent or continuous monitoring of blood glucose. 
Therefore, enzyme-based amperometric continuous glucose monitoring systems 
were first developed. Continuous ex vivo and in vivo monitoring of blood glucose 
was first proposed in the 1970’s and 1980’s, respectively [5]. In vivo continuous 
glucose monitoring would generate real-time data about the change of blood 
glucose levels. However, the development of reliable implantable glucose sensors 
is still very challenging. This is due to undesirable interactions between the 
implanted device and the biological medium cause rapid deterioration of 
amperometric sensor performance upon implantation [1(a)]. In addition, due to 
biofouling of the electrode surface by proteins and coagulation factors and the risk 
of thromboembolism, most continuous detectors do not measure blood glucose 
directly, and their stability and calibration to blood glucose levels have proven 
difficult [1(b)]. Recently, a tissue glucose amperometric sensor implanted for more 
than one year in an animal was reported, with promising results [6]. However, the 
need for surgical implantation of the device and potential adverse medical effects 
may limit its use by diabetic patients at home. Despite extensive research efforts 
in these areas over past years, no FDA approved reliable method is presently 
available for continuous long-term implantable tissue glucose monitoring [1(a)]. 
Alternatively, extensive efforts have been devoted over the past decade toward 
the design of subcutaneously implantable needle-type electrodes for short-term 
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measurement of glucose concentrations in interstitial fluid, which reflect the blood 
glucose level [1(a), 7]. To date, several needle-type continuous glucose sensors 
have been approved by U.S. FDA, including the Guardian REAL-time continuous 
glucose monitoring system, Dexcom SEVEN Plus, Medtronic’s MiniMed 
Paradigm REAL-Time System and iPro2. Although these ‘under-the-skin’ devices 
can display updated real-time glucose concentrations every one to five minutes, 
their lifetime is very limited (3-7 days) due to similar biofouling problems, as well 
as poor stability associated with the needle-type sensor [8]. Subcutaneous 
continuous glucose monitoring can also be achieved without direct contact 
between the interstitial fluid and transducer by using the microdialysis technique 
[9]. For example, glucoDay (Menarini, Florence, Italy) and SCGM (Roche, 
Mannheim, Germany) are based on a microdialysis technique. However, major 
challenges to long-term subcutaneous continuous glucose monitoring, including 
biocompatibility, linearity, calibration, specificity, drift and long-term stability, and 
miniaturization, still hamper their routine clinical usefulness. Other methods such 
as transdermal glucose sensor were also proposed as an alternative. Approved by 
the U.S. FDA, the GlucoWatch Biographer (Cygnus, Inc., Redwood City, CA, 
USA), is a watch-like electrochemical device based on transdermal extraction of 
interstitial fluid by reverse iontophoresis. However, it has not gained wide 
acceptance due to long warm-up time, false alarms, inaccuracy, skin irritation, and 
sweating. As a result, the GlucoWatch was withdrawn from the market in 2008. 
Thus, new glucose-sensing strategies need to be developed. Non-invasive and 
minimally invasive optical approaches thus come out as an alternative [10]. To 
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date, different optical techniques such as polarimetry [11], Raman spectroscopy 
[12], infrared absorption spectroscopy [13], photoacoustics [14], and optical 
coherence tomography [15] have been studied for non-invasive glucose detection. 
However, due to the complexity of tissues, reliable non-invasive optical glucose 
measuring methods are still unavailable. Another widely used optical glucose 
sensing method is fluorescence-based glucose sensor, which holds great promise 
for continuous glucose monitoring in vivo. 
 
1.2 Fluorescence-based glucose monitoring 
Fluorescence-based glucose monitoring method depends on principle of 
fluorescence, where fluorescence is the emission of light by a substance that 
absorbs light or other electromagnetic radiation. A fluorophore is a molecule that 
absorbs light at a particular wavelength and re-emits energy at a different 
wavelength. On addition of glucose to the fluorescence based glucose biosensor, 
the fluorescence either increases or decreases from the baseline with respect to 
the glucose concentration.  
In the past decades, various fluorescent glucose sensors have been developed 
based on the use of concanavalin A (Con A), GOx, GDH, hexokinase, apo-glucose 
oxidase, glucose binding protein, and boronic acid derivatives as the sensing 
elements in conjunction with various fluorophore reporters such as green 
fluorescence protein (GFP) through different sensing mechanism such as the 
measurement of the photo-induced electron transfer (PET) induced by glucose, 
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the measurement of fluorescence resonance energy transfer (FRET) induced by 
glucose-induced conformation change of proteins/enzymes, or glucose–induced 
changes in intrinsic fluorescence of enzymes [16, 17]. 
 
1.2.1 Concavalin A 
Concanavalin A (Con A) is one of the best characterized lectins, and it is mannose 
and glucose specific [18]. Con A is known for its affinity for polysaccharides. The 
lectin Con A is a glucose-mannose binding plant metalloprotein isolated from the 
jack bean [19] which requires both calcium and manganese cations to complete 
the formation of a saccharide binding site per protomer [20]. It is used in different 
types of glucose monitoring because of its four binding sites and reversible binding 
of sugars. 
The fluorescence based approaches for glucose detection using Concavalin A 
(Con A) is mainly due to the competitive bind between the four glucose binding 
sites of Con A and fluorescein-labeled analogue [16, 21]. For example, a turn-on 
non-invasive fluorescence based glucose biosensor, potentially suitable for 
subcutaneous implantation – like a tattoo using concanavalin A (Con A) 
incorporated with photopolymeriszed poly(ethylene glycol) (PEG) hydrogel has 
been reported. Here α- acryloyl, ω-N- hydroxysuc-cinimidyl ester of PEG-propionic 
acid are used to chemically conjugate physically immobilized fluorescein 
isothiocyanate dextran (FITC-dextran) and chemically immobilized pendant 
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tetramethylrhodamine isothiocyanate concanavalin A (TRITC-Con A) into a PEG 
hydrogel [3]. Fluorescence increasing as a result of glucose fluorescein-labelled 
dextran and concavalin A binding is shown in Figure 1. Upon glucose addition, the 
glucose preferentially binds with Con A and releases fluorescein-labelled dextran, 
thus increasing its fluorescence intensity when compared to fluorescein-labelled 
dextran complexed with ConA. Higher intensity of fluorescence emission will be 
observed with increase in glucose concentration [22]. 
 
Figure 1: Fluorescence optical detection based on binding affinity. 
On other hand, ConA fluorescence-based glucose sensors based on fluorescence 
emission between ConA as donor and fluorescein labeled dextran as acceptor 
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occurs as a result of FRET (foster resonance energy transfer), when they are 
within foster radius of each other [16, 19]. 
By evaluating FRET-induced fluorescence emission intensity of fluorescein-
labelled dextran, glucose concentrations can be monitored. This is due to the 
increase in distance between glucose and ConA more than forster distance. 
Thereby this results in decrease in FRET-induced fluorescence emission [23, 24]. 
 
Figure 2: Fluorescence optical detection based on decrease in FRET-induced 
fluorescence intensity. 
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Glucose concentrations can also be evaluated by monitoring changes in lifetime 
of the donor molecule as the occurrence of FRET between the donor and the 
acceptor molecules can be influenced by the lifetime of donor molecule. Increase 
of glucose concentration can enhance the lifetime of donor molecule to prevent 
decrease in FRET [16]. However, there is a need to improve the stability of ConA 
and also look for alternatives to Con A mainly because of its short lifetime. 
 
1.2.2 Boronic Acid 
In 1880, before boronic acid’s binding ability with diols was discovered, Michaelis 
and Becker synthesized phenylboronic acid (PBA) [25]. The ability of borates to 
interact with hydroxyl compounds was resolved when Kuivila and his group 
discovered that polyols and saccharides dissolve in boronic acid solutions [26].  
There have been several boronic acid based glucose sensing membranes 
reported in the literature [27], and also it has been well-understood that boronic 
acid derivatives can form stable complexes with carbohydrates using either 1,2- or 
1,3-diol groups [21]. In this regard, boronic acid based glucose sensors are 
designed mainly based on their ability of strongly and reversibly binding with diol 
moieties. In addition, boronic acids are synthetic receptors which could be 
incorporated into polymers [28, 29]. 
A glucose sensor based on photoindused electron transfer (PET) is observed in 
anthracene phenylboronate compounds. This dye is designed for fluorescent 
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saccharide measurement, and has weak or no fluorescence in the absence of 
saccharides [30, 31] due to the unshared electron pair of nitrogen atom which 
occupies lowest excited energy to suppress the fluorescence. In most of the 
solution based techniques when glucose reacts with boric acid, it increases the 
acidity of the solution [32] and changes boronic acid-appended fluorophore upon 
glucose binding by “switching on” fluorescence. The increase of fluorescence is 
due to the fact that the electron deficient boron atom had bound to electron rich 
nitrogen [33, 34] which could be studied using fluorescence spectroscopy [35, 36]. 
Figure 3 explains the basic mechanism of glucose sensing using fluorescent 
boronic acid [30, 31]. 
 
Figure 3: Boronic acid derivatives based fluorescence sensing mechanism for 
glucose. 
11 
 
Potentially, there are several ways to approach continuous, noninvasive glucose 
monitoring using boronic acid derivatives, including near-infrared (NIR) 
spectroscopy [37, 38], contact lens type of sensors [39] and implanted sensor 
devices [19]. Except for the direct spectroscopic method where a fluorescence 
spectroscopy is used to monitor fluorescence changes in boronic acids derivative 
upon glucose binding, the others require the use of a sensor as the recognition 
and transducer unit. 
One such example is from injectable hydrogel microbeads for fluorescence based 
in vivo continuous glucose monitoring [40], where fluorescent hydrogel fiber was 
prepared for glucose sensing. The fluorescence intensity of glucose-responsive 
fluorescent monomer increased depending on glucose molecules existence, 
followed by coupling it with diboronic acid and hydrophilic spacer by polymerization 
using polyethylene glycol (PEG) and acrylamide (AAm). Finally it was immobilized 
on polyacrylamide hydrogels possessing sparse and flexible matrix [40]. A 
reversible reaction between glucose responsive fluorescent monomer and glucose 
was observed where with increase in glucose concentration the fluorescent 
intensity increased and vice versa. Though it has credible results on one hand, it 
does not have substrate specificity on the other hand. 
Today, boronic acid – based glucose sensors can be used for both non-invasive 
and continuous glucose monitoring which indeed is an immense progress, 
specially the development of water soluble and photochemically stable fluorescent 
boronic acid derivatives. However, the short excitation and emission wavelengths 
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for most of these fluorescent boronic acid derivatives leave much to be desired. 
More work is needed to address these practical problems in order to develop a 
better glucose sensing system. 
 
1.2.3 Glucose binding protein and Hexokinase 
Binding proteins recognize only their respective substrates where the E. coli 
glucose binding protein (GBP) manly recognizes glucose for which it is employed 
as one of the glucose receptive molecule. These are soluble proteins found in 
periplasmic space of gram negative bacteria (e.g., E. coli), containing similar 
structure of sugar and other ligand binding proteins. Transporting molecules to the 
membrane receptors is the key role played by the binding proteins [41, 42]. These 
binding proteins are not enzymes and there is no requirement of additional 
ingredient for proceeding sensing mechanism. Thus they are considered as 
reagentless biosensors.  
Glucose binding proteins is used as a glucose sensor because it has a hinge like 
structure where a single polypeptide chain folds into two domains. The structure is 
explained in Figure 4 [43]. Because of their large intrinsic flexibility, on glucose 
binding the protein changes from an “open” ligand-free structure to a “closed” 
ligand-bound structure resulting in fluorescence change of a polarity sensitive 
fluorescent probe [44, 45].  
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Figure 4: Open and closed ribbon structures of glucose binding protein (GBP) 
depicting conformational change. 
 
Equivalent change in response to ligand binding can be indirectly detected. 
Corresponding optical results are micromolar sensitive to glucose allow us to 
monitor glucose levels, either through changes in FRET between donor-acceptor 
pairs on the protein or by change in fluorescence due to environmentally sensitive 
fluorophore [46, 47]. 
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A hexokinase is an enzyme that catalyzes the transfer of the γ phosphoryl group 
of ATP to the hydroxyl group at position C6 of glucose. For such activation a 
divalent metal ion such as 𝑀𝑔2+ or 𝑀𝑛2+ is required. 
 
Several groups reported that the hexokinase enzyme has intrinsic fluorescence 
with excitation and emission wavelengths to be ex=295 nm and ex=330 nm 
respectively, attributed to tryptophan residues in the protein-which exits in a 
dimeric form. Each monomer subunit of the enzyme bifurcates into two lobes, as 
shown in Figure 5.  
 
Figure 5: Closed conformation of Hexokinase induced by glucose binding.  
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Binding of glucose at the active site in the cleft leads to a conformational change 
in the enzyme, such that the two lobes move closer together and the glucose is 
almost surrounded by protein [48]. Each subunit of yeast hexokinase has four 
tryptophan residues as shown in Figure 6, domain 1 & 2 are two surface residues, 
domain 3 is a glucose quenchable residue at the cleft and domain 4 buried. 
Monitoring the fluorescence change on addition of glucose will thus provide 
information about glucose concentrations [48].  
 
 
 
Figure 6: Four tryptophan residues of yeast hexokinase.  
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1.2.4 Glucose oxidase 
Glucose oxidase is a small stable enzyme found in honey and is a natural 
preservative. It is a dimeric protein with 3D structure. Due to its high selectivity to 
glucose, significant pH range, ionic strength, and temperature, glucose oxidase 
detection yields maximum specificity for glucose estimation and has been widely 
applied in glucose detection [49-56]. 
Glucose oxidase is a glucose specific enzyme that plays the role of glucose 
receptor molecule and binds with fluorophore allowing energy transfer between 
flavin group of enzyme and the fluorescein [57]. Thus glucose oxidase is utilized 
as a glucose receptive molecule where the enzyme is immobilized in a polymer 
[58-68], which catalyzes oxidation of glucose to gluconic acid and hydrogen 
peroxide. In this process, flavin adenine mononucleotide (the enzyme’s redox 
cofactor) is converted to flavin adenine dinucleotide [1].  
 
 
 
In recent years many researchers started working on immobilizing glucose oxidase 
on various surfaces [69-72] for fabrication of glucose biosensors based on the 
concept of enzyme electrodes [73]. 
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Looking at the research in the past 5 years there could be seen different techniques 
adopted by researches to come up with fluorescence based glucose biosensor 
with an enzyme electrode. They commonly use the enzyme-glucose oxidase as 
their glucose receptive molecule. On addition of glucose the enzyme catalyzes by 
protonating the fluorophore, resulting in the fluorescence change of the biosensor 
with respect to glucose concentration. It could be either a “turn-on” response of 
fluorescence or a “turn-off” response depending on the technique adapted. 
For example, an optical glucose biosensor was recently fabricated by 
encapsulating glucose oxidase in silica gel via sol-gel method with Ru(bpy)3Cl2 as 
a luminescent oxygen transducer, for monitoring glucose concentrations in body 
blood and urine samples [74]. On addition of glucose ranging from 2 mM to 18 mM, 
oxidation occurs due to the enzyme catalysis. An increase in fluorescence of 
Ru(bpy)3Cl2 was observed due to oxygen consumption [74]. 
As mentioned above the enzyme catalyzes oxidation of glucose to gluconic acid 
and hydrogen peroxide. A “turn-on” response is observed in this case where the 
fluorescence intensity of the biosensor increases from its normal line, due to 
oxygen consumption. The fluorescent glucose biosensors can also be developed 
using the enzymatic product of hydrogen peroxide. Recently a glucose oxidase 
biosensor was developed based on Fenton reaction triggered molecular beacon 
cleavage. Initially a low fluorescence was observed due to high quenching 
efficiency in molecular beacons, but on addition of glucose, hydrogen peroxide is 
generated with the oxidation of glucose by the enzyme. *OH was produced through 
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Fe2+ catalyzed Fenton reaction and then triggered the cleavage of molecular 
beacon, resulting in increase of its fluorescence due to complete separation of the 
fluorophore from the quencher [75]. Thus a “turn-on” response is observed due to 
hydrogen peroxide generation. 
Similarly many techniques, including fluorophore and GOx functionalized gold 
nanoclusters as probe, GOx immobilized on layer-by-layer fluorophore films, etc., 
are also developed for glucose detection based fluorescence change [76]. 
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Objective 
 
Even though a variety of fluorescence biosensors based on different materials 
have been reported for the detection of glucose, a biocompatible fluorescence-
based glucose sensors with good sensitivity, excellent selectivity, reproducibility 
and stability, as well as low cost, are always highly demanded for quantitative 
determination of glucose. The major effort of this research focuses on the design 
of novel biocompatible glucose-responsive fluorescent hydrogel towards glucose 
detection. We are aiming at developing glucose sensors which have potential 
application for in vivo continuous glucose detection in a simple, sensitive, selective 
and cost-effective way.   
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Chapter 2 
Experimental Section 
2.1 Reagents and Equipment 
Glucose oxidase (GOx), fluorescein-o-acrylate (FOA), poly ethylene glycol 
diacrylate (PEGDA, M.W.=250) and glucose were obtained from Sigma-Aldrich. 
Tetramethylethylenediamine (TEMED) and ammonium persulfate (APS) were 
purchased from Bio-Rad. Solidum chloride, monosodium phosphate, disodium 
phosphate are acquired from Fisher. All solutions were prepared with deionized 
(DI) water (18.2 MΩ-cm) from a Barnstead DI water system. As human body fluid 
(e.g., blood) is a buffered solution consisting of NaCl ranging from 100 mM to 200 
mM, 20 mM pH 7.4 phosphate buffer solution with or without 150 mM NaCl were 
used in the study.  
Absorption spectra were performed on a Varian Cary 50 UV-Vis NIR 
spectrophotometer, and fluorescence emission spectra were recorded on a Varian 
Carry Elipse Fluorescence Spectrophotometer. Microplate reader (Biotek, synergy 
HT) was employed to measure the fluorescence of hydrogels in multi-well plate.  
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2.2 Measurement of pH-dependent fluorescence of fluorescein-o-acrylate in 
phosphate buffer solution 
To study the pH-dependent fluorescence of fluorescein-o-acrylate in phosphate 
buffer solution, 500 µg/mL of fluorescein-o-acrylate was dissolved in 20 mM 
phosphate buffer solution with different pH values (pH 5.8, pH 6.6, pH 7.4, and pH 
8.2). The corresponding UV-vis absorption and fluorescent emission spectra 
(ex=489 nm) were collected.    
2.3 Preparation of glucose-responsive fluorescent hydrogel  
To form a hydrogel, fluorescein-o-acrylate (FOA) and polyethylene glycol 
diacrylate (PEGDA) mixture containing GOx was polymerized with TEMED and 
APS as accelerator and initiator, respectively. The reaction is a vinyl addition 
polymerization initiated by a free radical-generating system. Chemical 
polymerization is initiated by APS (initiator) and TEMED (accelerator) which 
accelerates the formation of free radicals from persulfate thus catalyzing the 
polymerization. The persulfate free radicals convert FOA and PEGDA (both 
serving as monomers) to free radicals which react with inactivated monomers to 
start the polymerization. The elongating polymer chains are randomly crosslinked 
by PEGDA (also serving as crosslinker), resulting in a hydrogel with a 
characteristic porosity which depends on the polymerization conditions and 
monomer concentrations. Meanwhile, GOx was entrapped in the hydrogel 
simultaneously. FOA endows the hydrogel fluorescence and PEG introduces good 
biocompatibility to the hydrogel, while GOx endows the hydrogel glucose 
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responsiveness. Therefore, the as-prepared glucose-responsive fluorescent 
hydrogel provides an excellent biosensing platform for glucose monitoring.  
To prepare a typical 100 µL hydrogel, 49.33 µL 20 mM pH 7.4 sodium phosphate 
buffer solution, 20 µL of FOA solution (500 µg/mL in the same phosphate buffer 
solution), 10 µL of liquid PEGDA, 10 µL of GOx solution (100 mg/mL in 20 mM pH 
7.4 buffer), 0.66 µL of TEMED were mixed first. Then 10 µL of 1 wt% APS solution 
(in water) was added to trigger the polymerization.  
Once all chemicals are added, immediate vigorous mixing is required until 
polymerization starts. Within half a minute hydrogel was formed and the final GOx 
concentration in hydrogel is 10 mg/mL. GOx loading in hydrogel can be changed 
using different stock GOx solution. To prepare any other volume of hydrogel, the 
same volume ratio is applied. A schematic drawing of the crosslinked PEG-FOA 
hydrogel with GOx entrapped in the hydrogel matrix was shown in Figure 7.   
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Figure 7: Schematic representation of the cross-linked glucose-responsive 
fluorescent hydrogel (not in scale). 
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The as-prepared hydrogel appears to be pale yellow in color to naked eye under 
white light (Figure 8-A), while it displays a high green fluorescence under UV-light 
of 365 nm wavelength (Figure 8-B). 
 
 
 
 
 
 
 
 
Figure 8: (A) An optical image of the as-prepared hydrogel under white light; (B) A 
fluorescence image of the as-prepared hydrogel under 365 nm UV light. 
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Chapter 3 
Results and Discussion 
3.1 pH-dependent fluorescence of fluorescein-o-acrylate 
Fluorescein and many of its derivatives exhibit multiple, pH-dependent ionic 
equilibria. It has been proven that fluorescein is a pH-responsive fluorophore. In 
present work fluorescein-o-acrylate was used and then its pH-dependent 
fluorescence was investigated first. Solution based emission and absorption 
spectra of fluorescein-o-acrylate were collected and presented in Figure 9. One 
can see that the absorption and emission peaks of FOA were observed at 489 nm 
and 512 nm, respectively. With the increase of pH from pH 5.8 to pH 8.2, both the 
absorption peak intensity and emission peak intensity increase, showing a pH-
dependent behavior. This study indicates that FOA can also be employed as a 
reporter to local pH change.   
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Figure 9: UV-vis absorption (A) and emission (B) spectra of FOA in different pH 
buffer solution (ex=489 nm).  
 
In a basic medium an open structure of FOA is observed as shown in Figure 10. 
With the increase of acid concentration, a spiro structure or lactone structure of 
FOA is observed, resulting in the reduced fluorescence. Therefore, to lower the pH 
results in the “turn-off” of its fluorescence.  
 
 
 
 
Figure 10: The mechanism for pH-dependent fluorescence of FOA. 
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3.2 pH-dependent fluorescence of the as-prepared hydrogel 
 
 
Figure 11: SEM images of lyophilized PEG-FOA hydrogel (A,C) and PEG-FOA-
GOx (B,D) in high (A,B) and low (C,D) magnification. 
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The morphology of hydrogel was first evaluated using Jeol Field emission scanning 
electron microscope (JSM-6335F Thermo Electron Corporation). PEG-FOA 
hydrogel and PEG-FOA-GOx hydrogel were firstly prepared at room temperature 
and then subject to lyophilization. Figure 11 shows the corresponding SEM images 
of lyophilized hydrogels. As can be seen, both hydrogels show highly porous 
structures with pore size less than 10 µm. The incorporation of GOx in hydrogel 
(Figure 11, B and D) resulted in the hydrogel scaffold consisting of smaller 
particles.  
To investigate the pH-dependence of the fluorescence of as-prepared hydrogel, 
hydrogel was first prepared in multi-well plate with a volume of 150 µL/well. The 
same recipe described in Chapter 2 was used to prepare hydrogel in multi-well 
plate. Once the hydrogel was formed, fluorescence measurement was taken and 
the fluorescence of each hydrogel is almost same. Hydrogel in each well was then 
treated with 200 µL of 20 mM sodium phosphate buffer solution with pH value of 
pH 5.8, pH 6.6, pH 7.4 and pH 8.0, respectively. After 45 min interaction, 
fluorescence measurements were conducted in situ by taking the readings from a 
micro-plate reader. All experiments were carried out in triplicate. As shown in 
Figure 12, the fluorescence of the hydrogel decreases with pH decrease from 8.2 
to 5.8. The observed trend is in good agreement with pH-dependent fluorescence 
of FOA in solution (Figure 11B). 
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Figure 12: Fluorescence response of the as-prepared hydrogels upon the addition 
of 20 mM sodium phosphate buffer solution with different pH value (pH 5.8, pH 
6.6, pH 7.4 and pH 8.2). (ex=489 nm and em=512 nm). 
 
The fluorescence images of the hydrogels before and after addition of buffer 
solution with different pH values were also obtained under UV-light at 365 nm 
wavelength and presented in Figure 13. One can see that lower fluorescence 
intensity at acidic medium and higher fluorescence intensity in basic medium, in 
good agreement with the trend obtained from multiwall plate reader in Figure 13.  
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Figure 13: The fluorescence images of the hydrogel immediately after addition of  
20 mM sodium phosphate buffer solution and after 45 min of addition of 20 mM 
sodium phosphate buffer solution with different pH values (pH 5.8, pH 6.6, pH 7.4 
and pH 8.2) under a handheld UV-lamp (365 nm). 
 
These studies clearly indicate that the as-prepared hydrogel possesses pH-
dependent fluorescence and can respond to local pH change, which has the 
potential to be used as glucose biosensing material in conjunction with GOx-based 
enzymatic conversion of glucose to gluconic acid.  
 
3.3 Glucose response of the as-prepared PEG-FOA hydrogel and PEG-FOA-
GOx hydrogel 
To test the ability of the hydrogel whether or not it responds to glucose, two wells 
of PEG-FOA-GOx hydrogels (150 μL of hydrogel each well with GOx final 
concentration of 10 mg/mL) and another two wells of PEG-FOA hydrogel (150 μL 
of hydrogel each well without GOx) were prepared, and their fluorescence 
response to the addition of 200 μL DI water in the absence or presence of 30 mM 
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glucose was collected. There are four different experiments here: 1. the PEG-FOA 
hydrogel exposed to 200 μL DI water; 2. the PEG-FOA hydrogel exposed to 200 
μL DI water containing 30 mM glucose; 3. the PEG-FOA-GOx hydrogel exposed to 
200 μL DI water; and 4. The PEG-FOA-GOx hydrogel exposed to 200 μL DI water 
containing 30 mM glucose.  
Upon the addition of solution to the microplate well, fluorescence was measured 
every 15 min using a multi-well plate reader. To have a better comparison of the 
fluorescence change and eliminate the very minor variation of initial fluorescence 
intensity of hydrogels in different wells, normalized fluorescence intensity (I/I0) and 
normalized fluorescence intensity change, (I0-I)/I0, were used in Figure 14 and 
Figure 15, respectively. I0 is the initial fluorescence intensity at em=512 nm and I 
is the respective fluorescence reading at every 15 minutes after the addition of 
solution.  
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Figure 14: Normalized fluorescence intensity vs. time for PEG-FOA hydrogel and 
PEG-FOA-GOx hydrogel upon the addition of DI water with or without 30 mM 
glucose. (ex=489 nm and em=512 nm).  
 
Figure 15: Normalized fluorescence intensity change vs. time for PEG-FOA 
hydrogel and PEG-FOA-GOx hydrogel upon the addition of DI water with or without 
30 mM glucose. (ex=489 nm and em=512 nm). 
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The addition of DI water does not result in obvious fluorescence change for both 
PEG-FOA hydrogel and PEG-FOA-GOx hydrogel. The initial drop in fluorescence 
intensity may be attributed to the solvent and its diffusion effect. On the contrary, 
the addition of 30 mM glucose solution to PEG-FOA hydrogel and PEG-FOA-GOx 
hydrogel results in distinguishable response patterns. There is no obvious 
fluorescence intensity change observed for PEG-FOA hydrogel upon the addition 
of glucose due to the lack of GOx, while the fluorescence of PEG-FOA-GOx 
hydrogel gradually decreases and reaches saturation after 6 hours. The 
distinguished response pattern can be attributed to following mechanism. In the 
present of glucose, GOx catalyzes glucose and liberates gluconic acid (glucose+𝑂2
𝐺𝑂𝑥
→  gluconic acid+𝐻2𝑂2), resulting in the pH decrease in hydrogel. Consequently, 
pH-sensitive FOA responds to local pH change, resulting in the decrease of the 
fluorescence of hydrogel.  
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3.4 The effect of GOx loading on sensing performance of PEG-FOA-GOx 
hydrogel  
To further investigate the effect of GOx loading in PEG-FOA-GOx hydrogel on the 
glucose sensing performance, hydrogels with different GOx loading were first 
prepared with the same recipe in 20 mM pH 7.4 sodium phosphate buffer, and the 
final GOx concentration is 1 mg/mL, 10 mg/mL and 20 mg/mL, respectively. Upon 
the addition of 200 μL of 30 mM glucose, the fluorescence of hydrogels was 
collected every 15 minutes over 7 hours. The corresponding normalized 
fluorescence intensity and the normalized fluorescence intensity change with time 
were presented in Figure 16 and Figure 17. As expected, the hydrogel with higher 
GOx loading responded to glucose faster and then gradually reached plateau, 
while the hydrogel with lower GOx loading resulted in a slower response time. In 
addition, the experiments were further conducted to investigate the repeatability 
and consistency. The low relative standard deviation of less than 5.1% for triplicate 
experiments in all conditions here demonstrates good reproducibility of the 
developed glucose-sensing hydrogel.  
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Figure 16: The time-dependent normalized fluorescence intensity of PEG-FOA-
GOX hydrogels with different GOX loading upon the addition of 30 mM glucose. 
 
Figure 17: The time-dependent normalized fluorescence intensity change of PEG-
FOA-GOX hydrogels with different GOX loading upon the addition of 30 mM 
glucose.   
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As it is observed that sodium chloride (NaCl) concentration in human body fluids 
varies from the range 100 mM to 200 mM, hydrogels with different GOx loading 
were also prepared following in the same protocol except the use of 20 mM pH 7.4 
phosphate buffer containing 150 mM NaCl. Similar experiments as previous ones 
were further carried out to study glucose-sensing performance of hydrogel with 
various GOx loading upon the addition of 30 mM glucose. As shown in Figure 18, 
the normalized fluorescence intensity of hydrogel decreases with the increase of 
GOX loading from 1 mg/mL to 10 mg/mL to 20 mg/mL, which may be ascribed to 
the faster enzymatic conversion of glucose to gluconic acid. The corresponding 
normalized fluorescence intensity change is also presented in Figure 21. One can 
see that the higher loading of GOx in hydrogel results in a faster response and also 
reach saturation faster. However, given enough time (e.g., 7 hrs), all hydrogels 
could result in good fluorescence quenching of hydrogels. These results indicated 
that the presence of NaCl in hydrogel would not change the response pattern 
compared to the ones without NaCl. The low relative standard deviation of less 
than 5.1% for triplicate experiments in all conditions also demonstrates good 
reproducibility of the developed glucose-sensing hydrogel in the presence of NaCl.  
Furthermore, we can see from the results and the normalized data above that in 
the presence and absence of 15 mM NaCl, hydrogels with 20 mg/mL GOx possess 
a better glucose response in a faster way. However, hydrogel with 10 mg/mL GOx 
also shows good response to glucose addition. To consider the effect of GOx 
loading on sensing response and the cost of the use of expensive GOx, two 
different hydrogels were prepared for subsequent study in glucose detection: 1. 
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hydrogel with 20 mg/mL GOx prepared in buffer without 150 mM NaCl; and 2. 
hydrogel with 10 mg/mL prepared in buffer with 150 mM NaCl.  
 
 
Figure 18: The time-dependent normalized fluorescence intensity of PEG-FOA-
GOX hydrogels with different GOX loading upon the addition of 30 mM glucose.    
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Figure 19: The time-dependent normalized fluorescence intensity change of PEG-
FOA-GOX hydrogels with different GOX loading upon the addition of 30 mM 
glucose.   
 
3.5 Glucose detection 
3.5.1. Glucose sensing using PEG-FOA-GOx hydrogel prepared with 20 mM 
pH 7.4 sodium phosphate buffer (GOx loading of 20 mg/mL) 
The real-time fluorescence detection of glucose was carried out by injection of 
different glucose solution (0 to 50 mM) onto the as-prepared hydrogel in microplate 
wells. Right after the injection of solution, the fluorescence readings were recorded 
as the initial fluorescence values and then the fluorescence change of each 
hydrogel was recorded over time. The corresponding results were shown in Figure 
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12 and Figure 20. The injection of water barely caused any change in the 
fluorescence of hydrogel. With the injection of glucose, the normalized 
fluorescence intensity gradually decreases over time. The injection of glucose with 
higher concentration results in the fluorescence quench much faster and finally 
caused a lower saturated fluorescence when compared to the ones injected with 
low glucose concentration. The normalized fluorescence intensity change (Figure 
19) increases with the time when glucose concentration is fixed. In addition, at the 
same reaction time, higher glucose concentration results in a higher fluorescence 
change as expected. After 7 hours, the glucose solutions with 30 mM and 50 mM 
glucose can almost fully quench the fluorescence of hydrogel. This study indicates 
that the fluorescence of as-prepared hydrogel show concentration-dependent 
behavior toward glucose injection, which provides an excellent biosensing platform 
for glucose monitoring.  
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Figure 20: The time-dependent normalized fluorescence intensity of PEG-FOA-
GOX hydrogels prepared with 20 mM pH 7.4 sodium phosphate buffer (GOX 
loading=20 mg/mL) upon the addition of glucose solutions with different 
concentrations.    
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Figure 21: The time-dependent normalized fluorescence intensity change of PEG-
FOA-GOx hydrogels prepared with 20 mM pH 7.4 sodium phosphate buffer (GOx 
loading=20 mg/mL) upon the addition of glucose solutions with different 
concentrations. 
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Figure 22: The fluorescence images of PEG-FOA-GOx hydrogels prepared using 
20 mM pH 7.4 sodium phosphate buffer under UV-light at 365 nm immediately and 
after 7hrs addition of glucose solutions with different concentrations.  
 
Besides the fluorescence readings using microplate reader, the fluorescence 
images of the hydrogel immediately and after 7 hours addition of different glucose 
solution (0 mM glucose to 50 mM glucose) were also obtained under UV-light at 
365 nm wavelength and presented in Figure 22. One can see that the initial 
fluorescence of hydrogels is relatively uniform. Upon the addition of water, there is 
no obvious fluorescence difference in the hydrogels, but the addition of glucose 
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solution causes prominent fluorescence decrease of hydrogels. In addition, a 
decrease in fluorescence intensity was accompanied with increase in glucose 
concentrations added to the hydrogels. The decrease of fluorescence also shows 
concentration-dependent behavior, in good agreement with the observation from 
the microplate reader.   
 
3.5.2. Glucose sensing using PEG-FOA-GOx hydrogel prepared with 20 mM 
pH 7.4 sodium phosphate buffer containing 150 mM NaCl (GOx loading of 10 
mg/mL) 
Similar glucose detection experiments were also conducted using PEG-FOA-GOx 
hydrogel prepared with 20 mM sodium phosphate buffer containing 150 mM NaCl. 
As previous study also shows that 10 mg/mL GOx loading also possesses good 
response to glucose, a lower GOx loading (10 mg/mL) was used in this hydrogel in 
order to reduce the cost of GOx. As shown in Figure 23, one can see that the 
reduced loading of GOx does not change the response pattern too much compared 
to the one using 20 mg/mL, indicating that good glucose response can also be 
achieved with low GOx loading (low cost) in the presence of physiological level of 
NaCl. The corresponding time-depended normalized fluorescence intensity 
change is presented in Figure 24. The fluorescence images of the hydrogel 
immediately and after 7 hours addition of different glucose solution were also 
obtained under UV-light at 365 nm wavelength and presented in Figure 25. 
Compared the hydrogel without NaCl, this hydrogel’s initial fluorescence is slightly 
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weaker, which may be ascribed to the quench from higher ionic concentration. 
Similar as previous discussion, a concentration-dependent fluorescence was 
observed, which matches the fluorescence readings data very well.   
 
           
 
Figure 23: The time-dependent normalized fluorescence intensity of PEG-FOA-
GOX hydrogels prepared with 20 mM pH 7.4 sodium phosphate buffer containing 
150 mM NaCl (GOX loading=10 mg/mL) upon the addition of glucose solutions with 
different concentrations.    
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Figure 24: The time-dependent normalized fluorescence intensity change of PEG-
FOA-GOX hydrogels prepared with 20 mM pH 7.4 sodium phosphate buffer 
containing 150 mM NaCl (GOX loading=10 mg/mL) upon the addition of glucose 
solutions with different concentrations.    
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Figure 25: The fluorescence images of PEG-FOA-GOx hydrogels prepared using 
20 mM pH 7.4 sodium phosphate buffer containing 150 mM NaCl under UV-light 
at 365 nm immediately and after 7hrs addition of glucose solution with different 
concentrations.  
 
 
3.5.3. Glucose sensing using PEG-FOA-GOx hydrogel fiber (GOx loading of 
20 mg/mL) 
Inspiring from the high performance of the as-prepared hydrogel in glucose 
monitoring we have come up with a hydrogel fiber to improvise its response time. 
To form a hydrogel fiber the same procedure of forming hydrogel gel is followed 
where fluorescein-o-acrylate (FOA) and polyethylene diacrylate (PEGDA) mixture 
containing GOx was polymerized with TEMED and APS as accelerator and 
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initiator, respectively. 10% SDS solution is used to rinse the tubing first in order to 
reduce the friction between the fiber and the walls of the tube during extrusion 
process later. Before the mixture gets polymerized it is thoroughly mixed and 
loaded into a PVC tube of diameter 1/32 inches with the help of a syringe. Chemical 
polymerization initiated by APS (initiator) and TEMED (accelerator) which 
accelerates the formation of free radicals from persulfate catalyzes and 
polymerization takes place in the tube. The elongating polymer chains are 
randomly crosslinked by PEGDA (also serving as crosslinker), resulting in a 
hydrogel fiber in tubing. After the formation of hydrogel, the hydrogel fiber was 
extruded from the tubing and the as-prepared glucose-responsive fluorescent 
hydrogel fiber provides an excellent biosensing platform for glucose monitoring.   
Figure 26A and 26C explains the similar fluorescence intensity irrespective of 
forming a hydrogel or hydrogel fiber, when observed under UV-light of 365 nm 
wavelength. 
 
 
 
 
 
 
48 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. (A) Hydrogel formed in an eppendrof tube, (B) hydrogel fiber inside 
PVC tube of inner diameter 1/32 inches, and (C) hydrogel fiber after extrusion 
from the PVC tube and placed on a glass slide. 
 
Similar glucose detection experiments were also conducted using PEG-FOA-GOx 
hydrogel fiber prepared with 20 mM sodium phosphate. As previous study shows 
that 10 mg/mL GOx loading possesses good response to glucose in a hydrogel, 
similar GOx loading was used in the prepration of hydrogel fiber. FigureAs shown 
in Figure 27, three hydrogel fibers are treated in water, 20 mM glucose solution 
and 100 mM glucose solution, respectively. Within 5 min we could see a clear 
fluorescence decrease in the hydrogel fiber treated with 100 mM glucose. A similar 
fluorescence decrease is expected in the hydrogel fiber that is treated with 20 mM 
glucose, but since the fluorescence change is small when compared to sample 
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(C), it is not obvious to naked eye. This experiment indicated that hydrogel fiber 
shows much faster response upon the injection of glucose, which can be attributed 
to fast diffusion of glucose into hydrogel because of its small diameter.  
 
 
Figure 27: Glucose detection by FOA-PEG-GOx hydrogel fiber, sample (A) 
treated with water, sample (B) treated with 20 mM glucose solution and sample 
(C) treated with 100 mM glucose solution. 
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Chapter 4 
Conclusion and Future Direction 
4.1 Conclusion 
Throughout this thesis, we have explored a facile approach for the synthesis of 
PEG-FOA hydrogel with simultaneous entrapment of GOx. Taking the advantages 
of PEG and strong fluorescence of fluorescein, we used chemical polymerization 
to develop fluorescence hydrogel using PEG diacrylate and fluorescein-o-acrylate 
as monomers and PEG diacrylate as crosslinkers. The addition of GOx into 
polymerization solution resulted in glucose-responsive fluorescence hydrogel 
(PEG-FOA-GOx). As FOA is incorporated into the backbone of hydrogel, the 
leaching of fluorophore is significantly minimized, endowing the hydrogel stable 
fluorescence. Two types of hydrogels were prepared using 20 mM pH 7.4 sodium 
phosphate buffer with or without 150 mM NaCl. The presence of 150 mM NaCl in 
hydrogel preparation has no significant effect on glucose response pattern. The 
effect of GOx loading in hydrogel on biosensor response is also investigated. Then 
two hydrogels biosensors (different GOx loading) were applied for glucose 
detection. As glucose diffuses into the hydrogel, gluconic acid is produced due to 
GOx triggered enzymatic reaction. This enzymatic product then reacts with the 
fluorescein motif in the hydrogel, thus resulting in its fluorescence “turn-off”, which 
can be measured and correlated with glucose concentration.  
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This design of the biosensing system is efficient in glucose sensitivity and stability. 
However, since the hydrogel is prepared in a 96-well plate its thickness is relatively 
high for which glucose takes time to diffuse into the hydrogel. The delay in diffusing 
glucose into the hydrogel delays the reaction between glucose and the enzyme, 
accordingly. Though the observed quenching efficiency is relatively good, the 
performance can be further improved using fluorescence hydrogel fiber. Due to the 
small diameter of the hydrogel fiber (~750 m), glucose can quickly diffuse into 
hydrogel fiber and thus a faster response towards glucose injection could be 
observed. As PEG has well-documented biocompatibility, the as-developed 
glucose-responsive fluorescent hydrogel and hydrogel fiber hold great promise in 
the development of injectable glucose biosensors for continuous glucose 
monitoring.   
4.2 Future Direction: 
As the developed glucose-responsive hydrogel shows good response to glucose, 
some of future tasks are proposed. First, in vitro continuous glucose sensing can 
be conducted to further evaluate the sensing performance of the developed PEG-
FOA-GOx hydrogel because glucose concentration in human body continuously 
changes, thus requiring continuous monitoring. Therefore, a simulated in vitro 
continuous glucose sensing can be conducted in a PDMS microfluidic system. In 
this future study, the as-prepared hydrogel fiber will be fixed on glass slide first. 
Standard soft lithography techniques are then applied to create 
polydimethylsiloxane (PDMS) microfluidic channels. To complete the device 
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fabrication the PDMS channel will be put on the top of fixed hydrogel fiber and 
bonded to the glass, and then assembled with appropriate connectors (inlet and 
outlet) to form a microfluidic system. Due to the transparency of PDMS and glass, 
their presence would not affect taking fluorescence images of fluorescent PEG-
FOA-GOx hydrogel fiber in microfluidic channel. By regulating the perfusion rate 
of glucose solution with different concentrations, real-time glucose monitoring can 
be achieved through the capture of the fluorescent images of hydrogel fiber 
followed by analysis using ImageJ software. The long-term stability (or lifetime) of 
the developed glucose-responsive hydrogel will also be investigated by keeping 
running the experiments at 37 °C. After in vitro study, in vivo study can be further 
carried out using a rat subcutaneous model in conjunction with the biocompatibility 
study.  
 
Figure 28: PDMS microfluidic channel for CGM. 
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